FDA seeking access to ADE data bases for adverse drug event analysis through $1.4 mil. grant program.
Executive Summary
FDA SEEKS DATA BASES TO ADDRESS DRUG SAFETY QUESTIONS IN A TIMELY MANNER through a $1.4 mil. grant offered "for cooperative agreements to study adverse effects of marketed drugs, biologics and devices," a Feb. 5 Federal Register notice states. The agency expects to make four to six awards between $250,000 and $350,000 and hopes to find data bases "with a population of at least 2 mil. current enrollees." Applications are due by March 21.